Home / ELI Lilly & CO (LLY)
Sponsor pipeline · LLY

ELI Lilly & CO

Forward clinical-stage catalysts linked to LLY

11
Tracked catalysts (sample)
4
Clinical-stage assets
2026-08-31
Nearest catalyst
retatrutide
READOUT · Phase 32026-08-31
orforglipron
READOUT · Phase 32026-11-30
tirzepatide
READOUT · Phase 32026-11-30
lebrikizumab
READOUT · Phase 32027-04-25
!

Data, not investment advice. CSA is information, not a recommendation to buy, sell or hold any security. Estimated catalyst dates routinely slip and are graded by confidence — verify against the source link before acting.

This sponsor's catalysts are a slice of the free CSA sample. The full snapshot spans 139 listed sponsors and 2,103 forward catalysts.

Get the full dataset — $499 →